相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis and biological evaluation of new embelin derivatives as CK2 inhibitors
Sandra Oramas-Royo et al.
BIOORGANIC CHEMISTRY (2020)
Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening
Chunqiong Li et al.
MOLECULES (2020)
Design of CK2β-Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells
Dirk Lindenblatt et al.
CHEMMEDCHEM (2019)
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site
Benoit Bestgen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action
Benoit Bestgen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Shaoyong Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment
Ke Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders
Mark E. Gurney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Small molecule modulators targeting protein kinase CK1 and CK2
Yuting Qiao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors
Irina Kufareva et al.
SCIENTIFIC REPORTS (2019)
Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity
Shan Tang et al.
MOLECULAR INFORMATICS (2019)
Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein-protein interaction
Jessica Iegre et al.
CHEMICAL SCIENCE (2019)
Novel non-ATP competitive small molecules targeting the CK2 α/β interface
Paul Brear et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies
Yue Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Second-generation CK2α inhibitors targeting the αD pocket
Jessica Iegre et al.
CHEMICAL SCIENCE (2018)
A novel allosteric site in casein kinase 2α discovered using combining bioinformatics and biochemistry methods
Hai-ming Jiang et al.
ACTA PHARMACOLOGICA SINICA (2017)
A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066
Claudia De Fusco et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Melissa M. J. Chua et al.
PHARMACEUTICALS (2017)
The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design
Giorgio Cozza
PHARMACEUTICALS (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Casein kinases as potential therapeutic targets
Giorgio Cozza et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Emerging Computational Methods for the Rational Discovery of Allosteric Drugs
Jeffrey R. Wagner et al.
CHEMICAL REVIEWS (2016)
A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition
Hyeongki Kim et al.
DISEASE MODELS & MECHANISMS (2016)
Underlying mechanisms of cyclic peptide inhibitors interrupting the interaction of CK2α/CK2β: comparative molecular dynamics simulation studies
Yue Zhou et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)
Specific inhibition of CK2 alpha from an anchor outside the active site
Paul Brear et al.
CHEMICAL SCIENCE (2016)
Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity
Odile Filhol et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Allosteric small-molecule kinase inhibitors
Peng Wu et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Antitumoral activity of allosteric inhibitors of Protein kinase CK2
Virginie Moucadel et al.
Oncotarget (2015)
Drugs for Allosteric Sites on Receptors
Cody J. Wenthur et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features
Zhizhou Fang et al.
ACS CHEMICAL BIOLOGY (2013)
First Structure of Protein Kinase CK2 Catalytic Subunit with an Effective CK2β-Competitive Ligand
Jennifer Raaf et al.
ACS CHEMICAL BIOLOGY (2013)
The Dark Side of Protein Kinase CK2 Inhibition
G. Cozza et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2
Renaud Prudent et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
New Protein Kinase CK2 Inhibitors: Jumping out of the Catalytic Box
Renaud Prudent et al.
CHEMISTRY & BIOLOGY (2009)
The CK2α/CK2β interface of human protein kinase CK2 harbors a binding pocket for small molecules
Jennifer Raaf et al.
CHEMISTRY & BIOLOGY (2008)
Identification of chemical inhibitors of protein-kinase CK2 subunit interaction
Beatrice Laudet et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction
Beatrice Laudet et al.
BIOCHEMICAL JOURNAL (2007)
Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme
K Niefind et al.
EMBO JOURNAL (2001)
分享论文
